Ayca Erkin-Cakmak, MD, MPH

Dr. Ayca Erkin-Cakmak is a pediatric endocrinologist who cares for children with conditions related to hormonal issues. These include obesity, thyroid disorders, hormone-related growth disorders, metabolic syndrome (having a combination of health factors that increases the risk of heart disease and type 2 diabetes), and endocrine conditions associated with iron overload from thalassemia (an inherited blood disorder that can lead to anemia).

Erkin-Cakmak's research focuses on how exposures to certain chemicals in early childhood can affect the endocrine system and later development of obesity and metabolic syndrome. She is also interested in endocrine issues related to blood transfusions given to treat thalassemia.

Erkin-Cakmak earned her medical degree from Istanbul University Cerrahpasa Faculty of Medicine. She completed a residency in pediatrics and a fellowship in pediatric endocrinology as well as a fellowship in advanced research in pediatrics at UCSF. She also earned a master of public health degree from the University of California, Berkeley.

Erkin-Cakmak is a member of the Pediatric Endocrine Society, Endocrine Society and Obesity Society. She is originally from Turkey.
Education
6/2022 - Advanced Research in Pediatrics, Fellowship, University of California, San Francisco
06/2021 - Pediatrics Residency, University of California, San Francisco
05/2019 - Pediatric Endocrinology, Fellowship, University of California, San Francisco
MPH, 05/2013 - Maternal and Child Health, University of California, Berkeley
06/2009 - Pediatric Residency, University of Istanbul, Istanbul School of Medicine
MD, 07/2003 - Doctor of Medicine, University of Istanbul, Cerrahpasa School of Medicine

  1. Ayca Erkin-Cakmak, Tariq Ahmad, Anne Rishon, Marcela Weyhmiller, Ellen Fung, Maya Lodish, Ashutosh Lal. PSUN160 Transfusion Related Endocrinopathies and Thalassemia (TREAT) Study. Journal of the Endocrine Society 2022. PMID:


  2. Olson E, Suh JH, Schwarz JM, Noworolski SM, Jones GM, Barber JR, Erkin-Cakmak A, Mulligan K, Lustig RH, Mietus-Snyder M. Effects of Isocaloric Fructose Restriction on Ceramide Levels in Children with Obesity and Cardiometabolic Risk: Relation to Hepatic De Novo Lipogenesis and Insulin Sensitivity. 2022. PMID: 35406045


  3. Yasmin Bains, Ayca Erkin-Cakmak, Russell Caccavello, Kathleen Mulligan, Susan Noworolski, Jean-Marc Schwarz, Robert Lustig, Alejandro Gugliucci. Abstract 16511: Isocaloric Fructose Restriction Improves Postprandial Chylomicron and VLDL Excursions in Adolescents With Obesity by Reducing Angiopoietin-Like Protein 3 and Apolipoprotein CIII. Circulation 2020. PMID:


  4. AYCA ERKIN-CAKMAK, RYAN BAILEY, PETER CALHOUN, HAKAN CAKMAK, JENISE C. WONG. 1360-P: Infertility Is Not Associated with Clinical Factors in Women with Type 1 Diabetes (T1D). Diabetes 2020. PMID:


  5. Ayca Erkin-Cakmak, Hannah Chesser, Joseph Shieh, Christine Ferrara, Stephen Eric Gitelman, Gina Capodanno. SUN-690 HNF4A Mutation in Siblings with Diazoxide Responsive Congenital Hyperinsulinism. Journal of the Endocrine Society 2020. PMID:


  6. A. Gugliucci, Y. Bains, R. Caccavello, M. Wen, A. Erkin-Cakmak, K. Mulligan, R. Lustig, S. Noworolski, J.M. Schwarz. Short-Term Isocaloric Fructose Restriction Improves Postprandial Lipoprotein Subclass Profiles. Atherosclerosis 2019. PMID:


  7. Erkin-Cakmak A, Bains Y, Caccavello R, Noworolski SM, Schwarz JM, Mulligan K, Lustig RH, Gugliucci A. Isocaloric Fructose Restriction Reduces Serum d-Lactate Concentration in Children With Obesity and Metabolic Syndrome. The Journal of clinical endocrinology and metabolism 2019. PMID: 30869790


  8. Janet Lee, Alyssa Huang, Ayca Erkin-Cakmak, Jeanne Buchanan, Gina Capodanno. SAT-269 Insulin 101: Quality Education Strategies for Trainees (QuEST). Journal of the Endocrine Society 2019. PMID:


  9. Schwarz JM, Noworolski SM, Erkin-Cakmak A, Korn NJ, Wen MJ, Tai VW, Jones GM, Palii SP, Velasco-Alin M, Pan K, Patterson BW, Gugliucci A, Lustig RH, Mulligan K. Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity. Gastroenterology 2017. PMID: 28579536


  10. Gugliucci A, Lustig RH, Caccavello R, Erkin-Cakmak A, Noworolski SM, Tai VW, Wen MJ, Mulligan K, Schwarz JM. Short-term isocaloric fructose restriction lowers apoC-III levels and yields less atherogenic lipoprotein profiles in children with obesity and metabolic syndrome. Atherosclerosis 2016. PMID: 27451002


  11. Erkin-Cakmak A, Harley KG, Chevrier J, Bradman A, Kogut K, Huen K, Eskenazi B. Erratum: "In Utero and Childhood Polybrominated Diphenyl Ether Exposures and Body Mass at Age 7 Years: The CHAMACOS Study". Volume 124 of Issue 4. Environmental health perspectives 2016. PMID: 27035790


  12. Lustig RH, Mulligan K, Noworolski SM, Tai VW, Wen MJ, Erkin-Cakmak A, Gugliucci A, Schwarz JM. Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome. Obesity (Silver Spring, Md.) 2015. PMID: 26499447


  13. Erkin-Cakmak A, Harley KG, Chevrier J, Bradman A, Kogut K, Huen K, Eskenazi B. In utero and childhood polybrominated diphenyl ether exposures and body mass at age 7 years: the CHAMACOS study. Volume 123 of Issue 6. Environmental health perspectives 2015. PMID: 25738596


  14. Cengiz E, Sherr JL, Erkin-Cakmak A, Weinzimer SA, Burke EN, Sikes KA, Urban AD, Tamborlane WV. A bridge to insulin pump therapy: twice-daily regimen with NPH and detemir insulins during initial treatment of youth with type 1 diabetes mellitus. Volume 17 of Issue 6. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2011. PMID: 21550949